Cytokinetics Inc. (CYTK) Financials
Key financial figures for Cytokinetics Inc. (Q2 2026).
- Revenue
- $29M
- Net Income
- -$199M
- EPS
- $-1.50
- Total Assets
- $1.9B
- Operating Cash Flow
- -$160M
Full income statement, balance sheet, and cash flow for Cytokinetics Inc. on SentiSense.